2015
DOI: 10.1021/acs.chemrev.5b00201
|View full text |Cite
|
Sign up to set email alerts
|

Peptoids and Polypeptoids at the Frontier of Supra- and Macromolecular Engineering

Abstract: Scheme 3. Different Approaches Toward (Poly)(β-peptoid)s that Have Been Described in Literature a a Reprinted with permission from ref 39.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
208
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 229 publications
(208 citation statements)
references
References 404 publications
0
208
0
Order By: Relevance
“…poly(E-N-benzyloxycarbonyl-L-lysine), [99] poly(g-benzyl-L-glutamate), [99] poly(g-tert-butyl-L-glutamate), [100] and poly(S-ethylsulfonyl-L-cystine)], [101] PNMG-b-poly(E-caprolactone), [102] PNMG-b-poly[2-(3-butenyl)-2-oxazoline], [57] PNMG-b-(Leu-Aib) n [(Leu-Aib) n : helical peptides], [103][104][105][106][107][108][109][110] PNMG-b-poly(L-lactide) (AB, A 2 B, A 3 B types), [111] dextran-b-PNMG, [112] PEG-b-PNMG, [42] and C n512-18 -PNMG lipopolymers. [113][114][115] Their solution aggregation behavior has been reviewed by Luxenhofer et al [30] and will not be repeated here. We will highlight several recent examples of block copolypeptoid-based solution aggregates, particularly those that exhibit stimuli-responsive characteristics in dilute or semidilute solutions.…”
Section: Immunogenicitymentioning
confidence: 96%
See 2 more Smart Citations
“…poly(E-N-benzyloxycarbonyl-L-lysine), [99] poly(g-benzyl-L-glutamate), [99] poly(g-tert-butyl-L-glutamate), [100] and poly(S-ethylsulfonyl-L-cystine)], [101] PNMG-b-poly(E-caprolactone), [102] PNMG-b-poly[2-(3-butenyl)-2-oxazoline], [57] PNMG-b-(Leu-Aib) n [(Leu-Aib) n : helical peptides], [103][104][105][106][107][108][109][110] PNMG-b-poly(L-lactide) (AB, A 2 B, A 3 B types), [111] dextran-b-PNMG, [112] PEG-b-PNMG, [42] and C n512-18 -PNMG lipopolymers. [113][114][115] Their solution aggregation behavior has been reviewed by Luxenhofer et al [30] and will not be repeated here. We will highlight several recent examples of block copolypeptoid-based solution aggregates, particularly those that exhibit stimuli-responsive characteristics in dilute or semidilute solutions.…”
Section: Immunogenicitymentioning
confidence: 96%
“…[90,96] 30 ] were rapidly captured by the liver upon second administration [97] and cleared from the bloodstream, whereas the micelles to that of at the first administration. [90] This has been attributed to the significantly reduced interaction of the micelles with densely grafted polysarcosine corona with the B lymphocyte receptors and hence the suppression of antibody production.…”
Section: Immunogenicitymentioning
confidence: 99%
See 1 more Smart Citation
“…Due to the consequent lack of the polar N–H bonds, their lipophilicity is increased, which may result in improved membrane permeability [1617]. Furthermore, peptoids have also found utility in supra- and macromolecular engineering [18] and polymer chemistry [19]. Nevertheless, the lack of constraints in peptoids may result in a lower affinity for macromolecular targets, which limits their utility [20].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Peptoids are a class of robust, informationrich, chemically-diverse peptidomimetic polymers composed of N-substituted glycine monomers. 3 Like peptides, they have the ability to adopt distinct secondary structures such as ribbons, 4 helices, 5,6 sheets, 7 turns, 8 and cyclic structures; 9,10 however, the lack of a backbone hydrogen bond donor (NH) and chirality forces peptoid oligomers to conform to different folding rules as compared to their peptide counterparts. 11 Peptoids can be engineered to adopt multiple two and three-dimensional supramolecular assemblies including superhelices, 12 multi-helical bundles 13,14 and two-dimensional nanosheets.…”
mentioning
confidence: 99%